In order to produce potent new leads for antidiabetic drugs, a new series of isoindoline-1,3-dione analogues bearing aryl sulfonylurea moieties were synthesized and screened for their antihyperglycemic activity. Some of newly synthesized compounds were identified as active antihyperglycemic agents.
INTRODUCTION
It is clear that isoindoline-1,3-dione nucleus is the backbone of many bioactive compounds that show versatile biological and pharmacological activities ( WHO estimates that more than 180 million people worldwide have diabetes. The incidence of diabetes is increasing with alarming mortality and morbidity and This number is likely to more than double (http://www. afro.who.int/en/clusters-a-programmes/dpc/noncomm unicable-diseases-managementndm/programme-components/ diabetesmellitus.html. 2013).
There is an increasing demand of new antidiabetic products due to the drawbacks associated with insulin and oral hypoglycemic agents actually available (Fertig, et al.,1995) . In response to the enormity of the growing problem, efforts to identify and develop new pharmacological agents for type II diabetes have increased dramatically in recent years (http://diabetes manager.pbworks.com/w/page/ 17680289/Oral%20Pharmacological%20 Agents%20for%20Type%202%20Diabetes, 2013). These efforts have resulted in the successful introduction of several new treatment options.
Currently, there is a very important class of oral pharmacological agents available to treat type II diabetes, sulfonylureas (Nadendla, 2005). More recently, 2 nd generation sulfonylureas are now widely used as an effective antihyperglycemic agents with a lower risk of adverse as compound V (Korytkowski, 2004; Kar, 2006) .
From the previously mentioned findings, it was decided to synthesize some new compounds bearing both isoindoline-1,3-dione and sulfonylurea moieties hoping to obtain more effective antihyperglycemic agents.
For preparation of the newly synthesized compounds, the scheme 1 was adopted: 
Chemistry
Reaction of sulfonamide derivatives with phthalic anhydride derivatives in glacial acetic acid gave compounds VI a-f that act as key compounds. The target compounds VII a-u were obtained through the reaction of compounds VI a-f with alkyl/alicyclic isocyanate derivatives in dry acetone and anhydrous potassium carbonate.
Experimental
All melting points were taken on electrothermal (IA 9000 SERIS) digital melting point apparatus and are uncorrected. IR spectra were recorded on Pye Unicam SP 1000 IR spectrophotometer at Pharmaceutical analytical Unit, Faculty of Pharmacy, AlAzhar University. The 1 H NMR spectra were recorded in DMSO-d 6 at 300 MHz on a Varian Mercury VXR-300 NMR spectrometer at Research Services Unit, Faculty of Science, Cairo University. Chemical shifts were related to those of the solvent. Tetramethylsilane (TMS) was used as a standard. Mass spectra were recorded on Hewlett Packard 5988 spectrometer at Regional Center for Mycology and Biotechnology, Al-Azhar University. Microanalyses were carried out at Regional Center for Mycology and Biotechnology, Faculty of Science, AlAzhar University. Progresses of the reaction were monitored by TLC using TLC sheets precoated with UV fluorescent silica gel Merck 60 F254 plates and were visualized using UV lamp and dichloromethane : methanol 95:5 as mobile phase.
2.1.1. General procedure for the reaction of substituted isoindoline-1,3-dione with sulfonamide derivatives VI a-f : A mixture of sulfonamide derivative (0.02 mol) and phthalic anhydride (0.02mol) was refluxed in glacial acetic acid (50 mL) for 10 h. The solid obtained was filtered and washed with diluted ethanol to afford VI a-f . 2. 1.3. 4-(4,5,6,7-tetrabromo-1,3-dioxoisoindolin-2-yl) 
4-(

General procedure for synthesis of N-substituted bnzensulfonamide derivatives VII au :
Reaction mixture consisting of (0.002mol.) of VI a-f and (0.004 mol. 0.55 g) of anhydrous potassium carbonate in 150 ml of anhydrous acetone was stirred at refluxing temperature for about 1.5 h. (0.0025mol.) of the appropriate isocyanate was added dropwise to the reaction mixture. Refluxing and stirring were continued during the course of the addition and for an additional 16 hours. The acetone was removed by evaporation under reduced pressure, and about 750 ml of water were added to dissolve the resulting residue. The solution was filtered. Acidification of the filtrate with 6 N aqueous hydrochloric acid caused the precipitation of the product which was collected by filtration. Crystallization of the filter cake from 90% aqueous ethanol yielded purified sulfonylurea derivatives. 
N-(cyclohexylcarbamoyl) -4-(1,3-dioxoisoindolin-2 -yl) benzenesulfon
N-(cyclohexylcarbamoyl)-4-[(1,3-dioxoisoindolin-2-yl)methyl]benzenesulfonamide (VII
N-(cyclohexylcarbamoyl)-4-[2-(1,3-dioxoisoindolin-2-yl)ethyl]benzene-sulfonamide (VII
PHARMACOLOGY
Principle of Antihyperglycemic test
The test based on the method used by Ramsey et al. (Ramsey, et al., 2007) where the compounds to be tested or the standard (gliclazide) were given by oral route to groups of hyperglycemic adult male rats. After administration by three hours, the blood glucose level was determined and compared with standard.
Materials and Methods
Adult male rats (72 ± 10 days of age, weight ranging between 100 to 150 g) were injected intraperitoneally with streptozotocin (STZ), (60 mg/kg, Sigma) dissolved in 0.9% Sodium citrate buffer (pH 4.5) (Tanko, et al., 2008) . Blood glucose levels were measured 48-72 hrs after STZ administration and a value >350 mg/dl was considered to be diabetic. The diabetic rats were divided into three groups (i) drug treated group comprised of 12 subgroups for 12 test compounds, (ii) standard treated group and (iii) vehicle treated group. Each group as well as sub-group was comprised of 6 animals. The tested compounds as well as the standard drug were suspended in 5% gum acacia and administered by oral route at a dose of 200 mg/kg. After three hours, blood was drawn from the tail of conscious rats and the glucose content was estimated with using the (ACCU-CHEK Active) instrument and results were reported as mg/dl). 
STRUCTURE-ACTIVITY CORRELATION
Compounds belong to the unsubstituted isoindoline-1,3-dione proved to be more active than tetrabromo substituted one. Insertion of a one carbon spacer between the Nterminus of the isoindoline-1,3-dione and the phenyl moiety increased the hypoglycemic activity. Extending the spacer length to two carbons distance (as VII o , VII p, VII q and VII r ) produced the most active agent in this work, with 52 %, 48 % and 45 % reduction, respectively. It seemed that two carbons distance favor the interaction with the enzymatic receptors involved. The bulky and long chain alkyl groups on the N-substitution of the sulfonamide moiety produced higher activity than the less bulky and short alkyl one(cyclohexyl and butyl groups are more active than cyclopentyl and propyl groups respectively).
CONCLUSION
In the present study, certain new cyclic-imides isoindoline-1,3-diones and their isosters tetrabromoisoindole-1,3-diones bearing aryl sulfonyl urea moieties 
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